Abstract:BackgroundLarge-scale genetic screening using CRISPR-Cas9 technology has emerged as a powerful approach to uncover and validate gene functions. The ability to control the timing of genetic perturbation during CRISPR screens will facilitate precise dissection of dynamic and complex biological processes. Here, we report the optimization of a drug-inducible CRISPR-Cas9 system that allows high-throughput gene interrogation with a temporal control.ResultsWe designed multiple drug-inducible sgRNA expression vectors and measured their activities using an EGFP gene disruption assay in 11 human and mouse cell lines. The optimal design allows for a tight and inducible control of gene knockout in vitro, and in vivo during a seven-week-long experiment following hematopoietic reconstitution in mice. We next performed parallel genome-wide loss-of-function screens using the inducible and constitutive CRISPR-Cas9 systems. In proliferation-based dropout screens, these two approaches have similar performance in discriminating essential and nonessential genes. In a more challenging phenotypic assay that requires cytokine stimulation and cell staining, we observed similar sensitivity of the constitutive and drug-induced screening approaches in detecting known hits. Importantly, we demonstrate minimal leakiness of our inducible CRISPR screening platforms in the absence of chemical inducers in large-scale settings.ConclusionsIn this study, we have developed a drug-inducible CRISPR-Cas9 system that shows high cleavage efficiency upon induction but low background activity. Using this system, we have achieved inducible gene disruption in a wide range of cell types both in vitro and in vivo. For the first time, we present a systematic side-by-side comparison of constitutive and drug-inducible CRISPR-Cas9 platforms in large-scale functional screens. We demonstrate the tightness and efficiency of our drug-inducible CRISPR-Cas9 system in genome-wide pooled screening. Our design increases the versatility of CRISPR-based genetic screening and represents a significant upgrade on existing functional genomics toolbox.

Development of a tightly regulated copper-inducible transient gene expression system in incorporating suicide exon and Cre recombinase

Development of a tightly regulated copper-inducible transient gene expression system in Nicotiana benthamiana incorporating a suicide exon and Cre recombinase

Development of a Highly Efficient Copper-Inducible GAL Regulation System (cuigr) in Saccharomyces Cerevisiae

Chemical-regulated, site-specific DNA excision in transgenic plants

A copper switch for inducing CRISPR/Cas9-based transcriptional activation tightly regulates gene expression in Nicotiana benthamiana

Improvement of Copper-inducible Gene Expression System for Plant

Harnessing Endogenous Transcription Factors Directly by Small Molecules for Chemically Induced Pluripotency Inception.

A tunable, rapid, and precise drug control of protein expression by combining transcriptional and post-translational regulation systems

Inducible Excision of Selectable Marker Gene from Transgenic Plants by the Cre/lox Site-Specific Recombination System.

Inducible and reversible regulation of endogenous gene in mouse.

Synthetic Dual-Input Mammalian Genetic Circuits Enable Tunable and Stringent Transcription Control by Chemical and Light

Targeted single-cell gene induction by optimizing the dually regulated CRE/ loxP system by a newly defined heat-shock promoter and the steroid hormone in Arabidopsis thaliana

CRISPRi-mediated tunable control of gene expression level with engineered single-guide RNA in Escherichia coli

The robust, high-throughput, and temporally regulated roxCre and loxCre reporting systems for genetic modifications

Inducible Suppression of Fgfr2 and Survivin in ES Cells Using a Combination of the RNA Interference (rnai) and the Cre-LoxP System

Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening

A More Efficient RNAi Inducible System for Tight Regulation of Gene Expression in Mammalian Cells and Xenograft Animals.

A synthetic transcription platform for programmable gene expression in mammalian cells

Small-molecule inducible transcriptional control in mammalian cells

Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system

High-performance chemical- and light-inducible recombinases in mammalian cells and mice